Cited by 45Diabetes Management and EducationDiabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: the Microalbuminuria Education and Medication Optimisation (MEMO) Study

Open access
Crasto, W., Jarvis, J., Khunti, K., Skinner, T.C., Gray, L.J., Brela, J., Troughton, J., Daly, H. +4 more·2011·Diabetes Research and Clinical Practice

Abstract

Aims To determine whether tighter cardiovascular risk factor control with structured education in individuals with type 2 diabetes (T2DM) and microalbuminuria benefits cardiovascular risk factors. Methods Participants from a multiethnic population, recruited from primary care and specialist clinics were randomised to intensive intervention with structured patient (DESMOND model) education (n=94) or usual care by own health professional (n=95). Primary outcome change in HbA1c at 18months. Secondary outcomes changes in blood pressure (BP), cholesterol, albuminuria, proportion reaching risk factor targets, modelled cardiovascular risk scores. Results Mean (SD) age and diabetes duration of participants were 61.5 (10.5) and 11.5 (9.3) years, respectively. At 18months, intensive intervention showed significant improvements in HbA1c (7.1(1.0) vs. 7.8(1.4)%, p Conclusions Intensive intervention showed greater improvements in metabolic control and cardiovascular risk profile with lower rates of moderate and severe hypoglycaemia. Intensive glycaemic interventions should be underpinned by structured education promoting self-management in T2DM.

Integrity signals

Registry

Crossref · 10.1016/j.diabres.2011.05.008

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • An HbA1c target of ≤6.5% probably decreased the incidence of moderately increased albuminuria and kidney failure.

    “Six studies compared a target HbA1c of # 6.5% to higher HbA1c targets (standard glycemic control) and found that an HbA1c target of # 6.5% probably decreased the incidence of moderately increased albuminuria, and kidney failure (Supplementary Table S12 239,240,242 -244,252 )”

Cites

Flagged first, then by citations

2 of the 30 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Crasto, W., Jarvis, J., Khunti, K., Skinner, T. C., Gray, L. J., Brela, J., Troughton, J., Daly, H., Lawrence, I. G., McNally, P. G., Carey, M. E., & Davies, M. J.
Affiliations
  • University of Leicester (GB)
  • University Hospitals of Leicester NHS Trust (GB)
  • Flinders University (AU)
Corresponding author
Crasto, W.
Venue
Diabetes Research and Clinical Practice
Publisher
Elsevier BV
Published
2011-09
Volume
93
Issue
3
Pages
328-336
ISSN
0168-8227 (ISSN-L)
OpenAlex
W2049323164
Cited by
45
References
30
Citations by year
2025: 2 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 2 · 2019: 3 · 2018: 6 · 2017: 3 · 2016: 3 · 2015: 7 · 2014: 7 · 2013: 2 · 2012: 2
FWCI
2.88
Type
journal article
Language
en
Open access
Locations
  • Diabetes Research and Clinical Practice (publishedVersion)
  • PubMed (publishedVersion)
  • eCite Digital Repository (University of Tasmania) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • Figshare (submittedVersion)
  • Leicester Research Archive (University of Leicester) (submittedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
type 2 diabetes, microalbuminuria, patient education, self-management, tight glycemic control, HbA1c, blood pressure, cholesterol, cardiovascular risk factors, cardiovascular risk score, hypoglycemia, multifactorial intervention
MeSH terms
Adult, Aged, Aged, 80 and over, Albuminuria, Antihypertensive Agents, Hypolipidemic Agents, Aspirin, Blood Pressure, Cholesterol, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Male, Metformin, Middle Aged, Risk Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review